Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–15 of 15 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT06572423
- Conditions
- Head and Neck Carcinoma, Localized Head and Neck Carcinoma, Metastatic Head and Neck Carcinoma, +1 more
- Locations
-
- University of California at Los Angeles Los Angeles, California, United States
NCT03049618
- Conditions
- ALK Gene Mutation, BRAF Gene Mutation, Bronchial Neoplasms, +25 more
- Locations
-
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
NCT02467738
- Conditions
- Recurrent Head and Neck Carcinoma
- Locations
-
- Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States
NCT00954226
- Conditions
- Head and Neck Neoplasms, Mouth Diseases, Mouth Neoplasms, +9 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT02318771
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +39 more
- Locations
-
- Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States
NCT01638533
- Conditions
- Adenocarcinoma, Breast Diseases, Breast Neoplasms, +125 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
NCT03892720
- Conditions
- Recurrent Head and Neck Carcinoma
- Locations
-
- UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
NCT01846091
- Conditions
- Breast Diseases, Breast Neoplasms, Carcinoma, +21 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
Completed
Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations
NCT02646319
- Conditions
- Adenocarcinoma, Adnexal Diseases, Advanced Malignant Neoplasm, +73 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic Rochester, Minnesota, United States
NCT01696955
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +7 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
NCT01727076
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +47 more
- Locations
-
- Stanford Cancer Institute Palo Alto Palo Alto, California, United States
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
- University of Minnesota/Masonic Cancer Center Minneapolis, Minnesota, United States
- Seattle Cancer Care Alliance Seattle, Washington, United States
Active, Not Recruiting
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
NCT02465060
- Conditions
- Adenocarcinoma, Adnexal Diseases, Advanced Lymphoma, +138 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Thomas Hospital Fairhope, Alabama, United States
- Mobile Infirmary Medical Center Mobile, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
Active, Not Recruiting
Study Evaluating a Stereotactic Boost/Treatment for Recurrent or Metastatic Cancer of the Head and Neck
NCT02474368
- Conditions
- Head and Neck Cancer Metastatic, Head and Neck Neoplasms, Head or Neck Cancer, +3 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Active, Not Recruiting
Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
NCT04514484
- Conditions
- Adenocarcinoma, Adnexal Diseases, Advanced Differentiated Thyroid Gland Carcinoma, +141 more
- Locations
-
- Northwestern University Chicago, Illinois, United States
- Montefiore Medical Center-Einstein Campus The Bronx, New York, United States
- University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States
Active, Not Recruiting
Ramucirumab and Pembrolizumab vs Pembrolizumab Monotherapy in PD-L1 Positive Head and Neck Squamous-Cell Carcinoma
NCT05980000
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, HNSCC, +11 more
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States